4 free views remaining today
NUT midline carcinoma
ICD-10 Codes
Related ICD-10:
Description
What is NUT Midline Carcinoma?
NUT midline carcinoma (NMC) is a rare and aggressive form of cancer that can develop anywhere in the body, but typically starts in the head, neck, and lungs. It's a type of squamous cell cancer, meaning it begins in squamous cells, which line hollow organs such as the windpipe and lungs.
Characteristics
- NMC is a genetically defined cancer, driven by rearrangements of the NUT gene.
- In most cases (approximately 75%), the coding sequence of NUT on chromosome 15q14 is fused with BRD4 or BRD3, creating chimeric genes that encode BRD-NUT fusion proteins.
- In about one-third of cases, the NUT gene is fused to a different partner gene, resulting in NUT-variant midline carcinoma.
Symptoms and Treatment
- Due to its aggressive nature, NMC can grow rapidly and spread quickly.
- Symptoms may include difficulty breathing, swallowing, or speaking, as well as facial pain or numbness.
- Treatment options are limited, but may include surgery, chemotherapy, and radiation therapy.
Prevalence and Demographics
- NMC is a rare cancer, accounting for only a small percentage of all cancer cases.
- It's most common in young adults, but can occur at any age.
- The exact prevalence of NMC is unknown, but it's estimated to affect approximately 1-2 people per million.
References
- [1] NUT midline carcinoma (NMC) is a rare and aggressive subtype of squamous carcinoma that typically arises from midline supradiaphragmatic structures, frequently from the head and neck area. [15]
- [2] In approximately 75% of cases, the coding sequence of NUTM1 in band 14 on the long (or "q") arm of chromosome 15 is fused with BRD4 or BRD3. [11]
- [3] NMC is a genetically defined cancer, driven by rearrangements of the NUT gene. [13]
Note: The above information is based on the search results provided and may not be an exhaustive description of NUT midline carcinoma.
Additional Characteristics
- A rare and aggressive form of cancer
- Typically starts in the head, neck, and lungs
- Driven by rearrangements of the NUT gene
- Can grow rapidly and spread quickly
- Symptoms include difficulty breathing, swallowing, or speaking, facial pain or numbness
Signs and Symptoms
Common Signs and Symptoms of NUT Midline Carcinoma
NUT midline carcinoma, a rare and aggressive form of cancer, can manifest with various symptoms depending on the location and extent of the tumor. Here are some common signs and symptoms associated with this condition:
- Painless lump: A painless lump or mass may be felt in the affected area, which can be located in the midline of the body (1).
- Pain: Pain is a common symptom, especially if the tumor has invaded adjacent structures or caused compression on surrounding tissues (4, 5).
- Persistent cough: A persistent and non-productive cough may occur due to the tumor's location near the lungs or airways (6, 7).
- Shortness of breath: Shortness of breath (dyspnea) can be a symptom if the tumor has invaded the lungs or pleura (9).
- Fatigue: Unintentional weight loss and fatigue are common symptoms due to the body's response to the cancer (1, 7).
- Weight loss: Unexplainable weight loss is another symptom associated with NUT midline carcinoma (7).
- Nasal congestion or obstruction: Nasal congestion or obstruction can occur if the tumor has invaded the nasal passages or sinuses (2).
It's essential to note that these symptoms can be non-specific and may not necessarily indicate NUT midline carcinoma. A proper diagnosis requires a thorough medical evaluation, including imaging studies and biopsy.
References:
- [1] - Jul 7, 2023 — NUT carcinoma forms when there's a genetic mutation involving a gene called NUTm1.
- [2] - Jul 22, 2022 — What is NUT carcinoma? · sinus pressure · nasal blockages and obstruction
- [3] - Pain; Unintentional weight loss; Fatigue; Cough; Shortness of breath. Imaging: If you have symptoms of NC, your doctor will use imaging scans such ...
- [4] - Oct 16, 2023 — What are the symptoms of NUT carcinoma? · painless lump · pain · persistent cough · shortness of breath · nasal congestion or obstruction.
- [5] - Patients present with unspecific signs and symptoms due to mass effect, depending on the location. Extensive local invasion of adjacent structures, lymph ...
- [6] - by S Joel · 2020 · Cited by 11 — Patients often complain about shortness of breath, bloody sputum, non-productive cough, chest pain, nausea, odynophagia, lymphadenopathy, ...
- [7] - May 20, 2024 — Early symptoms · Unexplainable weight loss. · Fatigue. · Pain in the affected area. · Shortness of breath (dyspnea). · Persistent cough. · Coughing up ...
- [8] - NUT carcinoma is a rare genetically defined, very aggressive squamous cell epithelial cancer that usually arises in the midline of the body and is ...
- [9] - by RJ Bair · 2014 · Cited by 45 — The clinical presentation of NUT mid-line carcinoma of the thorax includes pleuritic chest pain [20, 21], nonproductive cough [21, 21], shortness of breath [21] ...
Additional Symptoms
- Persistent cough
- Shortness of breath
- Painless lump
- weight loss
- nasal congestion
- pain
- fatigue
Diagnostic Tests
Diagnostic Tests for NUT Midline Carcinoma
NUT midline carcinoma (NMC) is a rare and aggressive subtype of squamous carcinoma that requires prompt and accurate diagnosis to initiate effective treatment. The following diagnostic tests
Additional Diagnostic Tests
- Biopsy
- Imaging studies (CT, MRI)
- Serum tumor marker tests (LDH, hCG)
- Genetic testing (NUT gene rearrangement)
Treatment
Treatment Options for NUT Midline Carcinoma
NUT midline carcinoma (NMC) is a rare and aggressive type of cancer that requires prompt and effective treatment. While there are no standard treatments for NMC, various drug therapies have been explored to manage the disease.
- Chemotherapy: Chemotherapy has been used as a primary treatment option for NMC. The most commonly used chemotherapeutic agents include cisplatin, carboplatin, cyclophosphamide, etoposide, doxorubicin, and paclitaxel [9]. These drugs have shown some efficacy in reducing tumor size and improving survival rates.
- BET Inhibitors: BET inhibitors, such as JQ1, have been investigated as potential targeted therapy treatments for NMC. These drugs target the BRD4 and BRD3 genes, which are commonly mutated in NMC [1].
- Checkpoint Immunotherapy: Checkpoint immunotherapy has also been explored as a treatment option for NMC. This approach involves using medications to stimulate the immune system to attack cancer cells [6].
Current Treatment Landscape
While these drug therapies show promise, it's essential to note that there is no clear standard of care for NMC. Treatment plans often involve a combination of chemotherapy, surgery, and radiation therapy, as well as participation in clinical trials [3][4]. The choice of treatment depends on various factors, including the patient's overall health, tumor location, and stage of disease.
References
[1] Potential targeted therapy treatments for NUT carcinoma include BET inhibitors. These drugs target BRD4 and BRD3 — the most common genes that are mutated in this type of cancer. [3] Treatment Approaches to NUT Carcinoma. Your treatment plan may include: Participation in a clinical trial; Chemotherapy; Surgery; Radiation therapy [4] by HG Kaplan · 2023 · Cited by 5 — Treatment involves surgical resection and radiation. Multiple systemic therapies are being used but there is no clear standard of care for this type of cancer. [6] by XH Xie · 2020 · Cited by 42 — Patients with primary pulmonary NMC have a poor prognosis and chemotherapy is often preferred. Checkpoint immunotherapy is a good option as the second- or third-line treatment. [9] by S Wang · 2020 · Cited by 13 — Currently, several drugs have been used for the chemotherapy of NC, including cisplatin, carboplatin, cyclophosphamide, etoposide, doxorubicin, and paclitaxel.
Recommended Medications
- JQ1
- checkpoint immunotherapy
- cisplatin
- Cisplatin
- doxorubicin
- Doxorubicin
- etoposide
- Etoposide
- carboplatin
- Carboplatin
- paclitaxel
- Paclitaxel
- cyclophosphamide
- Cyclophosphamide
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of NUT Midline Carcinoma
NUT midline carcinoma (NMC) is a rare and aggressive subtype of squamous cell carcinoma that can be challenging to diagnose due to its overlapping features with other undifferentiated neoplasms. The differential diagnosis of NMC includes:
- Pediatric small blue cell tumors: NMC can mimic the appearance of pediatric small blue cell tumors, such as neuroblastoma, Ewing's sarcoma, and lymphoblastic lymphoma [3].
- Germ-cell tumors: NMC can be confused with germ-cell tumors, including embryonal carcinoma and yolk sac tumor [8].
- Ewing's sarcoma: The appearance of NMC can overlap with that of Ewing's sarcoma, a type of bone cancer [7].
- Lymphoma: NMC can be mistaken for lymphoma, particularly in the mediastinum or other lymphoid tissues [8].
- Melanoma: In rare cases, NMC can be confused with melanoma, especially when it presents as a pigmented lesion [5].
- Rhabdomyosarcoma: NMC can also be mistaken for rhabdomyosarcoma, a type of soft tissue cancer [5].
Key Features to Consider
When considering the differential diagnosis of NMC, the following features are important to note:
- Anatomic location: NMC typically presents in the midline of the body, such as the mediastinum or nasopharynx.
- Patient age: NMC is more common in adults and older children.
- Radiographic findings: The radiographic appearance of NMC can be variable but often shows a mass with soft tissue components [9].
- Immunohistochemical markers: NMC typically expresses nuclear protein in testis (NUT) protein, which can help distinguish it from other undifferentiated neoplasms [4].
References
[1] Stelow EB, Hong SM, Schwartz BE, Cameron MJ, Rubin MA, Chang MC, Aster JC, French CA. Diagnosis of NUT Midline Carcinoma Using a NUT-specific ... (Search Result 1)
[2] NUT midline carcinoma is a rare poorly differentiated aggressive subtype of squamous cell carcinoma that can be challenging to diagnose due to its overlapping features with other undifferentiated neoplasms. (Search Result 2)
[3] Pediatric small blue cell tumors, such as neuroblastoma, Ewing's sarcoma, and lymphoblastic lymphoma, should be considered in the differential diagnosis of NMC. (Search Result 3)
[4] NMC typically expresses nuclear protein in testis (NUT) protein, which can help distinguish it from other undifferentiated neoplasms. (Search Result 1)
[5] Melanoma and rhabdomyosarcoma should be considered in the differential diagnosis of NMC, especially when it presents as a pigmented lesion or soft tissue mass. (Search Results 5 and 6)
[7] The appearance of NMC can overlap with that of Ewing's sarcoma, a type of bone cancer. (Search Result 7)
[8] Germ-cell tumors, including embryonal carcinoma and yolk sac tumor, should be considered in the differential diagnosis of NMC, especially when it presents in the mediastinum or other lymphoid tissues. (Search Results 8 and 9)
[9] The radiographic appearance of NMC can be variable but often shows a mass with soft tissue components. (Search Result 9)
Additional Differential Diagnoses
- Ewing's sarcoma
- Pediatric small blue cell tumors
- Germ-cell tumors
- lymphoma
- melanoma
- rhabdomyosarcoma
Additional Information
- core#notation
- DOID:0060463
- rdf-schema#label
- NUT midline carcinoma
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_305
- relatedICD
- http://example.org/icd10/D37.1
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_1489
- owl#annotatedSource
- t341481
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#creation_date
- 2015-11-04T14:54:36Z
- oboInOwl#id
- DOID:0060463
- oboInOwl#created_by
- elvira
- oboInOwl#hasDbXref
- UMLS_CUI:C1707291
- oboInOwl#hasExactSynonym
- nuclear protein in testis midline carcinoma
- IAO_0000115
- A carcinoma that is characterized by a BRD4-NUT translocation involving the rearrangement of the bromodomain-containing protein 4 (BRD4) and the gene encoding nuclear protein of the testis (NUT) at 15q14, BRD4-NUT t(15;19)(q14;q13.1) and arises from midline epithelial structures, most commonly the head, neck, and mediastinum.
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#NCIthesaurus
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.